Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Transcend Biologics is a regenerative medicine company that specializes in the development and distribution of advanced biologic products for wound care, orthopedics, and surgical applications. The company provides a portfolio of human tissue-based allografts, including amniotic membranes and skin substitutes, designed to facilitate natural healing processes in complex clinical environments. Their products are primarily utilized for treating chronic wounds such as diabetic foot ulcers and venous leg ulcers, as well as supporting recovery in sports medicine and orthopedic surgery. By focusing on high-quality tissue processing and clinical efficacy, Transcend Biologics aims to improve patient recovery times and overall surgical outcomes. The company serves healthcare providers by bridging the gap between innovative biotechnology and practical clinical wound management.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Transcend Biologics.